New European patent approval for Episurf Medical
The European patent office EPO has announced its intention to grant another European patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Implant comprising a positioning mark” relates to an important feature of the Episealer® implant for accurate positioning in the joint. "This strengthens the IP protection in the European market for the Episealer® knee and ankle implants”, comments Katarina Flodström, COO, Episurf Medical.